Skip to main content

Table 4 Association of calculated threshold of main pancreatic duct (MPD) with malignancy in body-tail intraductal papillary mucinous neoplasms (IPMNs)

From: Threshold of main pancreatic duct for malignancy in intraductal papillary mucinous neoplasm at head-neck and body-tail

 

Univariate analysis

Multivariate analysis

OR

P value

OR

P value

MPD diameter (≥ 7.7 mm vs. < 7.7 mm)

4.93

(1.31–18.52)

0.018

9.83

(1.39–69.57)

0.022

Size (≥ 30 mm vs. < 30 mm)

4.97

(1.01–24.39)

0.048

3.65

(0.40–33.31)

0.25

CA19-9 (≥ 37 U/ml vs. < 37 U/ml)

14.17

(2.37–84.54)

0.004

28.69

(2.50–329.06)

0.007

Mural nodule (yes vs. no)

28.89

(3.01–277.02)

0.004

50.42

(2.79–912.89)

0.008

Diabetes Mellitus (yes vs. no)

1.17

(0.28–5.01)

0.83

2.21

(0.32–15.56)

0.42

CEA (≥ 5 vs. < 5 ng/ml)

0.72

(0.14–3.72)

0.69

0.32

(0.03–4.01)

0.38

  1. CA19-9 carbohydrate antigen 19-9, CEA carcinoembryonic antigen, OR odds ratio